CDC updates COVID-19 vaccine booster guidance as case counts rise
In a statement issued last week, the CDC expanded second booster eligibility for individuals 12 or older who are immunocompromised and those ages 50 and older. The agency cited a nationwide increase in COVID-19 cases as the reason for the update to the eligibility guidelines.
Top health official to step down this week, Wolf administration announces
Acting Department of Health Secretary Keara Klinepeter will resign at the end of the week.
Pa. Physician General discusses Neonatal Abstinence Syndrome in Crawford County
The overall NAS incidence rate in Pennsylvania is 11.9 cases per 1,000 live births, according to the Department of Health’s 2021 Neonatal Abstinence Syndrome report.
DOH cancer screening program offers free services to low, moderate-income patients
Known as The Pennsylvania Breast and Cervical Cancer Early Detection Program (PA-BCCEDP), the screening program offers free breast and cervical cancer detection services through the Pennsylvania Department of Health and is funded using grant money from the Centers for Disease Control and Prevention.
Wolf signs Alzheimer’s, dementia ‘toolkit’ bill into law | Five for the Weekend
“Our state’s aging population is one of the largest in the country, and it will only continue to grow. Legislation like this, which directly addresses the needs of Pennsylvania residents and establishes a foundation for future collaboration and intervention, are really where we see promise in Pennsylvania’s ability to address, and hopefully, curtail this public health crisis," Jennifer Ebersole, director of state government affairs for the Alzheimer’s Association said.
With Pa. Facing ‘critical shortage,’ state physician general issues call for donations
Speaking to reporters from the Central Pennsylvania Blood Bank in suburban Harrisburg, state Physician General Dr. Denise Johnson said the commonwealth is experiencing a shortage in its blood supply and urged eligible residents to donate blood.
COVID-19 still a ‘serious’ situation, Pa. Health Secretary Klinepeter says
As of Monday, the daily average number of COVID-19 cases in Pennsylvania was 11,405 with Tuesday case counts totaling more than 6,600 confirmed cases and more than 200 deaths.
Health Dept. adds regional long-term care sites to COVID-19 hospital support initiatives
In a briefing with reporters on Monday, acting state Health Secretary Keara Klinepeter said the addition of four regional long-term care support sites will “relieve pressure from hospitals and skilled nursing facilities” with a high number of patients with COVID-19.
As flu cases increase, state health officials urge Pennsylvanians to get vaccinated
Speaking to reporters in Montgomery County on Thursday, local leaders and officials from the state Health Department urged Pennsylvanians to get the flu vaccine to combat the growing number of cases this flu season.
Health experts worry CDC’s COVID-19 vaccination rates appear inflated | Analysis
Getting an accurate figure on the proportion of residents vaccinated is difficult for several reasons. The CDC and states may be using different population estimates. State data may not account for residents who get vaccinated in a state other than where they live or in clinics located in federal facilities, such as prisons, or those managed by the Veterans Health Administration or Indian Health Service.
Pa. Health Dept.: 2,639 hospitalized, 75 new deaths attributed to COVID-19
An unspecified “technical issue” has delayed the reporting of new COVID-19 case counts in Pennsylvania by the Department of Health. Due to the technical issue, the department did not report new cases of COVID-19 on Tuesday, but did provide updates on other COVID-19 statistics in Pennsylvania. As of Tuesday afternoon, 2,639 people were hospitalized with […]
Amid nationwide injectable Naloxone shortage, Pa. entities rely on Narcan supply
Naloxone, an injectable, intramuscular drug approved by the Food and Drug Administration for the rapid reversal of opioid overdoses, has been in scant supply since Pfizer, the drug’s maker, ran into manufacturing issues in 2020, causing the price of the Naloxone to soar even as demand for the drug increased during pandemic-fueled shutdowns, The Guardian reported earlier this month.